Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1432684
PUBLISHER: KBV Research | PRODUCT CODE: 1432684
Europe Pharmaceutical Suspension Market Size, Share & Trends Analysis Report By Type, By Distribution Channel, By End User, By Indication, By Country and Growth Forecast, 2023 - 2030
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Europe Pharmaceutical Suspension Market would witness market growth of 3.7% CAGR during the forecast period (2023-2030).
Suspensions are commonly used in the formulation of anti-infective drugs, particularly antibiotics. The suspension form allows for accurate dosing and convenient administration, making it suitable for various bacterial infections. This is crucial in assuring that patients receive the full course of treatment. Pharmaceutical suspensions are employed in formulating anti-inflammatory medications, providing a liquid dosage for patients with difficulty swallowing pills. This is particularly relevant in conditions such as arthritis, where long-term medication adherence is essential for managing symptoms.
Suspensions are utilized in ophthalmic formulations, allowing for the delivery of drugs directly to the eyes. Ophthalmic suspensions offer improved contact time with ocular tissues, ensuring effective treatment for eye infections or inflammation. In treating gastrointestinal disorders, pharmaceutical suspensions are employed to formulate medications that can address specific challenges in absorption or delivery within the gastrointestinal tract. This includes formulations for reflux, gastritis, or peptic ulcers. Suspensions are used to formulate diagnostic imaging agents, particularly in radiology. The suspension form allows for the controlled delivery of contrast agents, facilitating accurate imaging for diagnostic purposes.
With an aging population in Europe, there is a higher prevalence of chronic and age-related health conditions. Pharmaceutical suspensions offer the advantage of customized dosing, allowing healthcare providers to tailor medications to the specific needs of older patients in Europe. Thus, all these factors will uplift the regional market's expansion in the coming years.
The Germany market dominated the Europe Pharmaceutical Suspension Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $4,966.3 million by 2030. The UK market is exhibiting a CAGR of 2.8% during (2023 - 2030). Additionally, The France market would experience a CAGR of 4.4% during (2023 - 2030).
Based on Type, the market is segmented into Parenteral, Oral, and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Providers. Based on End User, the market is segmented into Hospitals and Clinics, Home Care Settings, and Others. Based on Indication, the market is segmented into Cancer, Neurological, Infectious Diseases, Gastrointestinal, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Merck & Co., Inc.
- Bayer AG
- Sanofi S.A.
- Pfizer, Inc.
- Novartis AG
- AstraZeneca PLC
- Glenmark Pharmaceuticals Limited
- Teva Pharmaceutical Industries Ltd.
- Eli Lilly And Company
- Lupin Limited
Europe Pharmaceutical Suspension Market Report Segmentation
By Type
- Parenteral
- Oral
- Others
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By End User
- Hospitals and Clinics
- Home Care Settings
- Others
By Indication
- Cancer
- Neurological
- Infectious Diseases
- Gastrointestinal
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Pharmaceutical Suspension Market, by Type
- 1.4.2 Europe Pharmaceutical Suspension Market, by Distribution Channel
- 1.4.3 Europe Pharmaceutical Suspension Market, by End User
- 1.4.4 Europe Pharmaceutical Suspension Market, by Indication
- 1.4.5 Europe Pharmaceutical Suspension Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter's Five Forces Analysis
Chapter 4. Strategies Deployed in Pharmaceutical Suspension Market
Chapter 5. Europe Pharmaceutical Suspension Market by Type
- 5.1 Europe Parenteral Market by Country
- 5.2 Europe Oral Market by Country
- 5.3 Europe Others Market by Country
Chapter 6. Europe Pharmaceutical Suspension Market by Distribution Channel
- 6.1 Europe Drug Store & Retail Pharmacies Market by Country
- 6.2 Europe Hospital Pharmacies Market by Country
- 6.3 Europe Online Providers Market by Country
Chapter 7. Europe Pharmaceutical Suspension Market by End User
- 7.1 Europe Hospitals and Clinics Market by Country
- 7.2 Europe Home Care Settings Market by Country
- 7.3 Europe Others Market by Country
Chapter 8. Europe Pharmaceutical Suspension Market by Indication
- 8.1 Europe Cancer Market by Country
- 8.2 Europe Neurological Market by Country
- 8.3 Europe Infectious Diseases Market by Country
- 8.4 Europe Gastrointestinal Market by Country
- 8.5 Europe Others Market by Country
Chapter 9. Europe Pharmaceutical Suspension Market by Country
- 9.1 Germany Pharmaceutical Suspension Market
- 9.1.1 Germany Pharmaceutical Suspension Market by Type
- 9.1.2 Germany Pharmaceutical Suspension Market by Distribution Channel
- 9.1.3 Germany Pharmaceutical Suspension Market by End User
- 9.1.4 Germany Pharmaceutical Suspension Market by Indication
- 9.2 UK Pharmaceutical Suspension Market
- 9.2.1 UK Pharmaceutical Suspension Market by Type
- 9.2.2 UK Pharmaceutical Suspension Market by Distribution Channel
- 9.2.3 UK Pharmaceutical Suspension Market by End User
- 9.2.4 UK Pharmaceutical Suspension Market by Indication
- 9.3 France Pharmaceutical Suspension Market
- 9.3.1 France Pharmaceutical Suspension Market by Type
- 9.3.2 France Pharmaceutical Suspension Market by Distribution Channel
- 9.3.3 France Pharmaceutical Suspension Market by End User
- 9.3.4 France Pharmaceutical Suspension Market by Indication
- 9.4 Russia Pharmaceutical Suspension Market
- 9.4.1 Russia Pharmaceutical Suspension Market by Type
- 9.4.2 Russia Pharmaceutical Suspension Market by Distribution Channel
- 9.4.3 Russia Pharmaceutical Suspension Market by End User
- 9.4.4 Russia Pharmaceutical Suspension Market by Indication
- 9.5 Spain Pharmaceutical Suspension Market
- 9.5.1 Spain Pharmaceutical Suspension Market by Type
- 9.5.2 Spain Pharmaceutical Suspension Market by Distribution Channel
- 9.5.3 Spain Pharmaceutical Suspension Market by End User
- 9.5.4 Spain Pharmaceutical Suspension Market by Indication
- 9.6 Italy Pharmaceutical Suspension Market
- 9.6.1 Italy Pharmaceutical Suspension Market by Type
- 9.6.2 Italy Pharmaceutical Suspension Market by Distribution Channel
- 9.6.3 Italy Pharmaceutical Suspension Market by End User
- 9.6.4 Italy Pharmaceutical Suspension Market by Indication
- 9.7 Rest of Europe Pharmaceutical Suspension Market
- 9.7.1 Rest of Europe Pharmaceutical Suspension Market by Type
- 9.7.2 Rest of Europe Pharmaceutical Suspension Market by Distribution Channel
- 9.7.3 Rest of Europe Pharmaceutical Suspension Market by End User
- 9.7.4 Rest of Europe Pharmaceutical Suspension Market by Indication
Chapter 10. Company Profiles
- 10.1 Merck & Co., Inc.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expenses
- 10.1.5 SWOT Analysis
- 10.2 Bayer AG
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
- 10.3 Sanofi S.A.
- 10.3.1 Company Overview
- 10.3.2 Financial Analysis
- 10.3.3 Segmental and Regional Analysis
- 10.3.4 Research & Development Expense
- 10.3.5 SWOT Analysis
- 10.4 Pfizer, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional & Segmental Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
- 10.5 Novartis AG
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expense
- 10.5.5 SWOT Analysis
- 10.6 AstraZeneca PLC
- 10.6.1 Company Overview
- 10.6.2 Financial Analysis
- 10.6.3 Regional Analysis
- 10.6.4 Research & Development Expenses
- 10.6.5 Recent strategies and developments:
- 10.6.5.1 Acquisition and Mergers:
- 10.6.6 SWOT Analysis
- 10.7 Glenmark Pharmaceuticals Limited
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Regional Analysis
- 10.7.4 Research & Development Expenses
- 10.7.5 SWOT Analysis
- 10.8 Teva Pharmaceutical Industries Ltd.
- 10.8.1 Company Overview
- 10.8.2 Financial Analysis
- 10.8.3 Regional Analysis
- 10.8.4 Research & Development Expenses
- 10.8.5 Recent strategies and developments:
- 10.8.5.1 Product Launches and Product Expansions:
- 10.8.6 SWOT Analysis
- 10.9 Eli Lilly And Company
- 10.9.1 Company Overview
- 10.9.2 Financial Analysis
- 10.9.3 Regional Analysis
- 10.9.4 Research & Development Expenses
- 10.9.5 Recent strategies and developments:
- 10.9.5.1 Partnerships, Collaborations, and Agreements:
- 10.9.6 SWOT Analysis
- 10.10. Lupin Limited
- 10.10.1 Company Overview
- 10.10.2 Financial Analysis
- 10.10.3 Regional Analysis
- 10.10.4 Research & Development Expense
- 10.10.5 Recent strategies and developments:
- 10.10.5.1 Partnerships, Collaborations, and Agreements:
- 10.10.5.2 Trials and Approvals:
- 10.10.6 SWOT Analysis
LIST OF TABLES
- TABLE 1 Europe Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 2 Europe Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 3 Europe Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 4 Europe Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 5 Europe Parenteral Market by Country, 2019 - 2022, USD Million
- TABLE 6 Europe Parenteral Market by Country, 2023 - 2030, USD Million
- TABLE 7 Europe Oral Market by Country, 2019 - 2022, USD Million
- TABLE 8 Europe Oral Market by Country, 2023 - 2030, USD Million
- TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 11 Europe Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 12 Europe Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 13 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 14 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 15 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 16 Europe Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 17 Europe Online Providers Market by Country, 2019 - 2022, USD Million
- TABLE 18 Europe Online Providers Market by Country, 2023 - 2030, USD Million
- TABLE 19 Europe Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 20 Europe Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 21 Europe Hospitals and Clinics Market by Country, 2019 - 2022, USD Million
- TABLE 22 Europe Hospitals and Clinics Market by Country, 2023 - 2030, USD Million
- TABLE 23 Europe Home Care Settings Market by Country, 2019 - 2022, USD Million
- TABLE 24 Europe Home Care Settings Market by Country, 2023 - 2030, USD Million
- TABLE 25 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 26 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 27 Europe Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 28 Europe Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 29 Europe Cancer Market by Country, 2019 - 2022, USD Million
- TABLE 30 Europe Cancer Market by Country, 2023 - 2030, USD Million
- TABLE 31 Europe Neurological Market by Country, 2019 - 2022, USD Million
- TABLE 32 Europe Neurological Market by Country, 2023 - 2030, USD Million
- TABLE 33 Europe Infectious Diseases Market by Country, 2019 - 2022, USD Million
- TABLE 34 Europe Infectious Diseases Market by Country, 2023 - 2030, USD Million
- TABLE 35 Europe Gastrointestinal Market by Country, 2019 - 2022, USD Million
- TABLE 36 Europe Gastrointestinal Market by Country, 2023 - 2030, USD Million
- TABLE 37 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 38 Europe Others Market by Country, 2023 - 2030, USD Million
- TABLE 39 Europe Pharmaceutical Suspension Market by Country, 2019 - 2022, USD Million
- TABLE 40 Europe Pharmaceutical Suspension Market by Country, 2023 - 2030, USD Million
- TABLE 41 Germany Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 42 Germany Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 43 Germany Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 44 Germany Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 45 Germany Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 46 Germany Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 47 Germany Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 48 Germany Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 49 Germany Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 50 Germany Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 51 UK Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 52 UK Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 53 UK Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 54 UK Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 55 UK Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 UK Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 UK Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 58 UK Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 59 UK Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 60 UK Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 61 France Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 62 France Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 63 France Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 64 France Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 65 France Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 France Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 67 France Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 68 France Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 69 France Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 70 France Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 71 Russia Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 72 Russia Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 73 Russia Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 74 Russia Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 75 Russia Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 76 Russia Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 77 Russia Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 78 Russia Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 79 Russia Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 80 Russia Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 81 Spain Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 82 Spain Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 83 Spain Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 84 Spain Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 85 Spain Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 86 Spain Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 87 Spain Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 88 Spain Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 89 Spain Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 90 Spain Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 91 Italy Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 92 Italy Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 93 Italy Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 94 Italy Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 95 Italy Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 96 Italy Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 97 Italy Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 98 Italy Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 99 Italy Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 100 Italy Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 101 Rest of Europe Pharmaceutical Suspension Market, 2019 - 2022, USD Million
- TABLE 102 Rest of Europe Pharmaceutical Suspension Market, 2023 - 2030, USD Million
- TABLE 103 Rest of Europe Pharmaceutical Suspension Market by Type, 2019 - 2022, USD Million
- TABLE 104 Rest of Europe Pharmaceutical Suspension Market by Type, 2023 - 2030, USD Million
- TABLE 105 Rest of Europe Pharmaceutical Suspension Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 106 Rest of Europe Pharmaceutical Suspension Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 107 Rest of Europe Pharmaceutical Suspension Market by End User, 2019 - 2022, USD Million
- TABLE 108 Rest of Europe Pharmaceutical Suspension Market by End User, 2023 - 2030, USD Million
- TABLE 109 Rest of Europe Pharmaceutical Suspension Market by Indication, 2019 - 2022, USD Million
- TABLE 110 Rest of Europe Pharmaceutical Suspension Market by Indication, 2023 - 2030, USD Million
- TABLE 111 Key Information - Merck & Co., Inc.
- TABLE 112 Key Information - Bayer AG
- TABLE 113 Key Information - Sanofi S.A.
- TABLE 114 Key Information - Pfizer, Inc.
- TABLE 115 Key Information - Novartis AG
- TABLE 116 KEY INFORMATION - AstraZeneca PLC
- TABLE 117 Key Information - Glenmark Pharmaceuticals Limited
- TABLE 118 Key Information - Teva Pharmaceuticals Industries Ltd.
- TABLE 119 Key Information - Eli Lilly And Company
- TABLE 120 Key Information - Lupin Limited
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.